Start Comparing Rates within Minutes!
Start Comparing Rates within Minutes and you could save!
Compare Rates Within Minutes!
- Complete 1 short quote form
- Compare rates from top insurers
- Save time & money!
FDA criticizes delay in Tylenol recallPosted On Tue, January 19, 2010
One month after the large-scale recall of certain Tylenol products from the market, the Food and Drug Administration is criticizing Johnson & Johnson for not acting sooner to initiate the recall.
On December 18, 2009, Johnson & Johnson issued a voluntary recall of all available lots of Tylenol Arthritis Pain Caplet 100 count bottles with the EZ-OPEN CAP after numerous customers reported that the pills had a moldy or mildew-like odor to them that was connected to stomach pain, vomiting, and diarrhea.
However, initial complaints of an odor problem in their products had been reported one month prior in November and only met with a minor recall of five lots.
"When something smells bad, literally and figuratively, you aggressively investigate and solve the problem," said Deborah Autor, director of FDA's compliance office, according to CNNMoney.
"All companies have a responsibility to ensure high quality, safety and effectiveness of their products and protect consumers," she added.
All preliminary research on the chemical that caused the odor - 2,4,6-tribromoanisole - found its health effects to be non-serious.
The delay in action to properly recall all of the affected products is an example of how a potentially dangerous product can be left on the market for an extended period before being noticed. For those who were affected by the defective Tylenol, having adequate health insurance coverage to handle any expensive is an important asset for one to have.
Feedback or questions? Email the editor here.